The (Cost-) Effectiveness of Mindfulness-training and Cognitive Behavioural Therapy in Adolescents and Young Adults With Deliberate Self Harm
DSH
1 other identifier
interventional
84
1 country
3
Brief Summary
Background: In recent years, there has been a marked rise in the frequency of young people engaging in Deliberate Self-Harm (DSH). DSH refers to all kinds of self-harming behaviour, with and without suicidal intent. Early identification and treatment of persons who engaged in DSH is important because every episode of DSH increases the risk of future episodes and, eventually, suicide. A number of comprehensive treatment programs have been developed and proven to be effective in reducing DSH in adults. Especially the modification of inadequate emotion regulation strategies seems to be essential in the prevention of future episodes of DSH. The first short-term results of a Dutch time-limited and structured individual cognitive-behavioral treatment (CBT) for DSH in adolescents and young adults also showed positive effects on repetition of DSH and associated problems. Objective: To study the effects and costs of the total individual CBT package and one of the components of the total CBT treatment package (i.e. mindfulness training) in a group format compared to Treatment-as-Usual (TAU) on the short and long term. Design: Multi-center randomized controlled clinical trial with repeated measurements at baseline (M0),and posttreatment (M6)), 12 (M12) and 18 months (M18) after baseline. Procedure: Young persons aged 15-35 who recently have engaged in DSH and have been referred to the Leiden University Medical Centre, the mental health centre Rivierduinen or the University Medical Centre St. Radboud following an act of DSH will be invited to participate. Persons reporting severe psychiatric disorders requiring intensive inpatient treatment or serious cognitive impairments will be excluded. Interventions: Participants are randomly allocated to CBT, Mindfulness-Based Cognitive Therapy(MBCT) or Treatment-as-Usual (TAU). The CBT treatment consists of up to 12 weekly sessions of individual treatment mainly consisting of emotion regulations skills, cognitive restructuring, and behavioural skills training. The MBCT training consists of 8 2-hour sessions in a group format within a three months time frame. Outcome measures: The same outcome measures to assess the clinical effects of treatment as in the previous study will be used (repetition of DSH, depression (BDI-II), anxiety (SCL-90), self-concept(RSC-Q), and suicide cognitions (SCS)) allowing a historical comparison of treatment effectiveness across both randomized clinical trials. In addition at all assessments health-related quality of life, use of medical resources and loss of productivity will be assessed (EuroQol, VAS and TTO). In addition,problems in emotion regulation (an important risk mechanism for repetition of DSH) will be assessed before and after treatment. Economic evaluation: Differences in societal costs (intervention, other (health) care and productivity)will be compared to differences in the frequency of DSH and quality adjusted life years (EuroQol, VAS and TTO). Data-analysis/power: Based on our previous study at least a medium effect of treatment on repetition of DSH may be expected. Assuming a medium effect of one of the treatments compared to TAU (delta =.75) and an attrition rate of about 20 %, at least 42 patients per study arm are needed to detect a minimal clinical relevant difference in repetition of DSH with a power of 80% and alpha set at .05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started May 2008
Typical duration for phase_2
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 5, 2008
CompletedFirst Posted
Study publicly available on registry
June 10, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedNovember 6, 2009
November 1, 2009
2.5 years
June 5, 2008
November 5, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Repetition of DSH, measured by the suicide attempt and self injury interview (SASII). Frequency, method and other characteristics of deliberate self-harm and suicide attempts are assessed.
M0, M6, M12, M18
Secondary Outcomes (15)
depression, as measured by the Beck depression Inventory II
M0, M6, M12, M18
Anxiety, as measured by the symptom checklist '90
M0, M6, M12, M18
Hostility, as measured by the symptom checklist '90
M0, M6, M12, M18
Self-concept, as measured by the Robson self-concept questionnaire
M0, M6, M12, M18
Suicidal cognitions, as measured by the suicidal cognitions scale
M0, M6, M12, M18
- +10 more secondary outcomes
Study Arms (2)
1
EXPERIMENTALCognitive Behavioural Treatment
2
EXPERIMENTALMindfulness Based Cognitive Therapy-training
Interventions
Eligibility Criteria
You may qualify if:
- Recently engaged in an act of DSH including overdose of medication, ingestion of chemical substances and self-inflicted injuries according to the definition which is used in the WHO/Euro Multicentre Study on parasuicide:"An act with non-fatal outcome in which an individual deliberately initiates a non-habitual behavior, that without intervention from other will cause self-harm, or deliberately ingests a substance in excess of the prescribed or generally recognized dosage, and which is aimed at realizing changes that the person desires via the actual or expected physical consequences"(Platt et al., 1992).
- Aged between 15 and 35
- Living in the region of Leiden or Nijmegen
You may not qualify if:
- Severe psychiatric disorder or substance abuse requiring intensive inpatient treatment
- Serious cognitive impairments
- Not be able to converse in Dutch
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University Medical Centre St. Radboud
Nijmegen, Gelderland, Netherlands
Leiden University Medical Centre
Leiden, South Holland, Netherlands
Rivierduinen Mental Health Centre
Leiden, South Holland, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Philip Spinhoven, Prof. dr.
Leiden University, Institute for Psychological Research
- STUDY DIRECTOR
Arnold A.P. van Emmerik, Dr.
Leiden University, Clinical Psychology Unit
- STUDY DIRECTOR
Anne E. van Giezen, Dr.
Leiden University, Institute for Psychological Research, Clinical Psychology Unit
- STUDY CHAIR
Anne E.M. Speckens, Prof. dr.
Radboud University Medical Center
- PRINCIPAL INVESTIGATOR
Suzanne de Klerk, MSc.
Leiden University, Institute for Psychological Research, Clinical Psychology Unit
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 5, 2008
First Posted
June 10, 2008
Study Start
May 1, 2008
Primary Completion
November 1, 2010
Study Completion
October 1, 2012
Last Updated
November 6, 2009
Record last verified: 2009-11